Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies

Journal of the Neurological Sciences

Volumn 349, Issue 1-2, 2015, Pages 45-51

  Fukasawa, Raita ^a   Hanyu, Haruo ^a   Shimizu, Soichiro ^a   Kanetaka, Hidekazu ^a   Sakurai, Hirofumi ^a   Ishii, Kenji ^a,b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Alzheimer disease; Dementia; Diabetes mellitus; Diabetes related dementia; Pittsburgh compound B PET; Single photon emission CT

Indexed keywords

AMYLOID; CHOLINESTERASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; IOFETAMINE I 123; MEMANTINE; PITTSBURGH COMPOUND B;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DIABETES RELATED DEMENTIA; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; FRONTAL LOBE; GAMMA CAMERA; HUMAN; IMAGE RECONSTRUCTION; IMAGING SOFTWARE; INSULIN TREATMENT; LEFT HEMISPHERE; LIMBIC CORTEX; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PARIETAL LOBE; PARIETOTEMPORAL LOBE; PATHOPHYSIOLOGY; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; RIGHT HEMISPHERE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; TEMPORAL LOBE; BRAIN; BRAIN CIRCULATION; LONGITUDINAL STUDY; SCINTISCANNING; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84922987888     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.12.023     Document Type: Article

References (28)

1. G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens Risk of dementia in diabetes mellitus: a systemic review Lancet Neurol 5 2006 64 74
2. R. Fukazawa, H. Hanyu, T. Sato, S. Shimizu, S. Koyama, and H. Kanetaka Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging Dement Geriatr Cogn Disord 35 2013 280 290
3. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
4. P. Scheltens, D. Leys, F. Barkhof, D. Huglo, H.C. Weinstein, and P. Vermersch Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates J Neurol Neurosurg Psychiatry 55 1992 967 972
5. S. Minoshima, K.A. Frey, R.A. Koeppe, N.L. Foster, and D.E. Kuhl A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET J Nucl Med 36 1995 1238 1248
6. H. Hanyu, T. Sato, K. Hirao, H. Kanetaka, T. Iwamoto, and K. Koizumi The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study J Neurol Sci 290 2010 96 101
7. S. Mizumura, S. Kumita, K. Tanaka, K. Cho, N. Sato, H. Nakajo, and M. Toba Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation Ann Nucl Med 17 2003 289 295
8. S. Kataoka, M. Paidi, and B.V. Howard Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype Clin Chem 40 1994 11 13
9. F.J. Bonte, T.S. Harris, L.S. Hynan, E.H. Bigio, and C.L. White III Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation Clin Nucl Med 31 2006 376 378
10. K.A. Jobst, L.P.D. Barnetson, and B.J. Shepstone Accurate prediction of histopathologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and ApoE4 in medial temporal lobe dementias Int Psychogeriatr 10 1998 271 302
11. N.J. Dougall, S. Bruggink, and K.P. Ebmeier Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia Am J Geriatr Psychiatry 12 2004 554 570
12. K. Herholz, A. Nordberg, E. Salmon, D. Perani, J. Kessler, and R. Mielke Impairment of neocortical metabolism predicts progression in Alzheimer's disease Dement Geriatr Cogn Disord 10 1999 494 504
13. Y. Nagahama, H. Nabatame, T. Okina, H. Yamauchi, M. Narita, and N. Fujimoto Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease Eur Neurol 50 2003 1 9
14. N. Wolfe, B.R. Reed, J.L. Eberling, and W.J. Jagust Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease Arch Neurol 52 1995 257 262
15. W.J. Jagust, M.N. Haan, B.R. Reed, and J.L. Eberling Brain perfusion imaging predicts survival in Alzheimer's disease Neurology 51 1998 1009 1013
16. 18F-FDG PET for detection of Alzheimer's disease J Nucl Med 48 2007 547 552
17. N.J. Cairns, M.D. Ikonomovic, T. Benzinger, M. Storandt, A.M. Fagan, and A.R. Shah Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report Arch Neurol 66 2009 1557 1562
18. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 2004 306 319
19. Y. Saito, N.N. Ruberu, M. Sawabe, T. Arai, N. Tanaka, and Y. Kakuta An age-associated tauopathy J Neuropathol Exp Neurol 63 2004 911 918
20. M. Yamada Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis Neuropathology 23 2003 311 317
21. J. Takeuchi, H. Shimada, S. Ataka, J. Kawabe, H. Mori, and K. Mizuno Clinical features of Pittsburgh compound-B-negative dementia Dement Geriatr Cogn Disord 34 2012 112 120
22. T. Adachi, Y. Saito, H. Hatsuta, S. Funabe, A.M. Tokumaru, and K. Ishii Neuropathological asymmetry in argyrophilic grain disease J Neuropathol Exp Neurol 69 2010 737 744
23. M. Brundel, J. de Bresser, J.J. van Dillen, L.J. Kappelle, and G.J. Biessels Cerebral microinfarcts: a systematic review of neuropathological studies J Cereb Blood Flow Metab 32 2012 425 436
24. S. van Rooden, J.D.C. Goos, A.M. van Opstal, M.J. Versluis, A.G. Webb, and G. Jan Blauw Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging Radiology 270 2014 205 211
25. M. Brundel, Y.D. Reijmer, S.J. van Veluw, H.J. Kuijf, P.R. Luijten, and L.J. Kappelle Cerebral microvascular lesions on high-resolution 7-tesla MRI in patients with type 2 diabetes Diabetes 63 2014 3523 3529
26. R. Fukasawa, H. Hanyu, N. Namioka, H. Hatanaka, T. Sato, and H. Sakurai Elevated inflammatory markers in diabetes-related dementia Geriatr Gerontol Int 14 2014 229 231
27. C.R. Jack Jr., H.J. Wiste, S.D. Weigand, D.S. Knopman, V. Lowe, and P. Vemuri Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity Neurology 81 2013 1732 1740
28. M. Wirth, S. Villeneuve, C.M. Haase, C.M. Madison, H. Oh, and S.M. Landau Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people JAMA Neurol 70 2013 1512 1519